Cipla Misses Profit Estimates
Indian drugmaker Cipla reported a 35 percent drop in quarterly profit, missing analyst estimates due to a sharp slowdown in its key United States market. Revenue from North America fell 19 percent as generic drug sales moderated, causing company shares to slip.
Xurve View
Insights:
Xurve View

CIPLA LTD posted a 35% drop in second-quarter profit on Tuesday, missing analyst estimates as weakness in the United States offset domestic growth.










